Literature DB >> 22350658

Further evidence that FSH causes bone loss independently of low estrogen.

Jameel Iqbal, Harry C Blair, Alberta Zallone, Li Sun, Mone Zaidi.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22350658     DOI： 10.1007/s12020-012-9626-y

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  36 in total

1.  FSH directly regulates bone mass.

Authors:  Li Sun; Yuanzhen Peng; Allison C Sharrow; Jameel Iqbal; Zhiyuan Zhang; Dionysios J Papachristou; Samir Zaidi; Ling-Ling Zhu; Beatrice B Yaroslavskiy; Hang Zhou; Alberta Zallone; M Ram Sairam; T Rajendra Kumar; Wei Bo; Jonathan Braun; Luis Cardoso-Landa; Mitchell B Schaffler; Baljit S Moonga; Harry C Blair; Mone Zaidi
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

2.  THE METABOLIC EFFECTS OF STEROID HORMONES IN OSTEOPOROSIS.

Authors:  E C Reifenstein; F Albright
Journal:  J Clin Invest       Date:  1947-01       Impact factor: 14.808

Review 3.  Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss.

Authors:  Mone Zaidi; Charles H Turner; Ernesto Canalis; Roberto Pacifici; Li Sun; Jameel Iqbal; X Edward Guo; Stuart Silverman; Solomon Epstein; Clifford J Rosen
Journal:  Curr Osteoporos Rep       Date:  2009-12       Impact factor: 5.096

4.  Follicle-stimulating hormone promotes RANK expression on human monocytes.

Authors:  Joseph G Cannon; Barbara Kraj; Gloria Sloan
Journal:  Cytokine       Date:  2010-12-14       Impact factor: 3.861

5.  Hormone predictors of bone mineral density changes during the menopausal transition.

Authors:  MaryFran R Sowers; Mary Jannausch; Daniel McConnell; Roderick Little; Gail A Greendale; Joel S Finkelstein; Robert M Neer; Janet Johnston; Bruce Ettinger
Journal:  J Clin Endocrinol Metab       Date:  2006-01-10       Impact factor: 5.958

6.  Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation.

Authors:  Jameel Iqbal; Li Sun; T Rajendra Kumar; Harry C Blair; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

7.  Protective effects of follicle-stimulating hormone inhibitor on alveolar bone loss resulting from experimental periapical lesions in ovariectomized rats.

Authors:  Shengbo Liu; Yong Cheng; Wangmin Xu; Zhuan Bian
Journal:  J Endod       Date:  2010-04       Impact factor: 4.171

8.  Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.

Authors:  Haruko Kawai; Madoka Furuhashi; Nobuhiko Suganuma
Journal:  Arch Gynecol Obstet       Date:  2003-09-12       Impact factor: 2.344

9.  Follicle-stimulating hormone does not impact male bone mass in vivo or human male osteoclasts in vitro.

Authors:  Veronique Ritter; Barbara Thuering; Pierre Saint Mezard; Ngoc-Hong Luong-Nguyen; Yves Seltenmeyer; Uwe Junker; Brigitte Fournier; Mira Susa; Frederic Morvan
Journal:  Calcif Tissue Int       Date:  2008-05-09       Impact factor: 4.333

10.  Follicle stimulating hormone and its rate of change in defining menopause transition stages.

Authors:  MaryFran R Sowers; Huiyong Zheng; Daniel McConnell; Bin Nan; Sioban Harlow; John F Randolph
Journal:  J Clin Endocrinol Metab       Date:  2008-07-22       Impact factor: 5.958
View more
  9 in total

Review 1.  Bone, brain & beyond.

Authors:  Alexandre Chamouni; Christiane Schreiweis; Franck Oury
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

2.  Bone mineral density in older patients with never-treated congenital hypogonadotropic hypogonadism.

Authors:  Luigi Maione; Annamaria Colao; Jacques Young
Journal:  Endocrine       Date:  2017-06-02       Impact factor: 3.633

3.  Micro-computed tomography assessment of bone structure in aging mice.

Authors:  Junbo Shim; Chihiro Iwaya; Catherine G Ambrose; Akiko Suzuki; Junichi Iwata
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

4.  FSH suppression does not affect bone turnover in eugonadal men.

Authors:  Alexander V Uihlein; Joel S Finkelstein; Hang Lee; Benjamin Z Leder
Journal:  J Clin Endocrinol Metab       Date:  2014-03-19       Impact factor: 5.958

5.  The role of enteric hormone GLP-2 in the response of bone markers to a mixed meal in postmenopausal women with type 2 diabetes mellitus.

Authors:  Laura S Girão Lopes; Rubens Prado Schwartz; Bruno Ferraz-de-Souza; Maria Elizabeth Rossi da Silva; Pedro Henrique Silveira Corrêa; Márcia Nery
Journal:  Diabetol Metab Syndr       Date:  2015-02-27       Impact factor: 3.320

6.  Manipulation of Ovarian Function Significantly Influenced Trabecular and Cortical Bone Volume, Architecture and Density in Mice at Death.

Authors:  Jeffrey B Mason; Boston C Terry; Samer S Merchant; Holly M Mason; Mahdi Nazokkarmaher
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

Review 7.  Crosstalk of Brain and Bone-Clinical Observations and Their Molecular Bases.

Authors:  Ellen Otto; Paul-Richard Knapstein; Denise Jahn; Jessika Appelt; Karl-Heinz Frosch; Serafeim Tsitsilonis; Johannes Keller
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

8.  Follicle-stimulating hormone impairs dental pulp stem cells odontogenic differentiation.

Authors:  Hua Qian; Xiaoyue Guan
Journal:  J Cell Mol Med       Date:  2020-07-28       Impact factor: 5.310

9.  A Follicle-Stimulating Hormone Exacerbates the Progression of Periapical Inflammation Through Modulating the Cytokine Release in Periodontal Tissue.

Authors:  Hua Qian; Jie Jia; Ying Yang; Zhuan Bian; Yaoting Ji
Journal:  Inflammation       Date:  2020-08       Impact factor: 4.657
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.